Text Size
47 studies found for:    " January 23, 2008":" February 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" January 23, 2008":" February 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Conditions: Lipodystrophy;   HIV Infections
Intervention: Drug: TH9507
2 Terminated Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: EnvDNA, PolyEnv1, EnvPro
3 Completed FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada®;   Drug: Placebo
4 Unknown † Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
Condition: HIV Infections
Interventions: Behavioral: HIV-related text messaging;   Behavioral: Nutrition-related text messaging
5 Recruiting Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
Condition: HIV Infections
Intervention: Procedure: Male Circumcision
6 Unknown † Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
7 Unknown † Early Versus Delayed Routine HIV Testing in Connecticut Jails
Condition: HIV Infections
Intervention: Other: routine HIV testing
8 Terminated
Has Results 		MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
9 Active, not recruiting Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
10 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
11 Completed A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
Condition: HIV Infections
Interventions: Drug: Dapivirine Gel 4750, 0.05%, 2.5g;   Drug: Dapivirine Gel 4789, 0.05%, 2.5g;   Drug: HEC-based Placebo Gel
12 Completed Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241 AM3)(COMPLETED)
Condition: HIV Infections
Intervention: Drug: Vicriviroc
13 Completed Naïve HIV POC Monotherapy Trial
Condition: HIV Infections
Interventions: Drug: RDEA806;   Drug: Placebo
14 Active, not recruiting Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine
15 Completed Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
16 Completed
Has Results 		PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
17 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
18 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
19 Completed Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
20 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years